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Background: We have revealed that the type II diacylglycerol kinases (DGKs) δ, η and κ were expressed in the
testis and ovary. However, these enzymes’ functions in the reproductive organs remain unknown.
Results: In this study, we first identified the expression sites of type II DGKs in the mouse reproductive organs in detail.
Reverse transcription-polymerase chain reaction and Western blotting confirmed that DGKδ2 (splicing variant 2) but not
DGKδ1 (splicing variant 1) and DGKκ were expressed in the testis, ovary and uterus. DGKη1 (splicing variant 1) but not
DGKη2 (splicing variant 2) was strongly detected in the ovary and uterus. Interestingly, we found that a new alternative
splicing product of the DGKη gene, DGKη3, which lacks exon 26 encoding 31 amino acid residues, was expressed only
in the testis. Moreover, we investigated the distribution of type II DGKs in the testis, ovary and uterus through in situ
hybridization. DGKδ2 was distributed in the primary spermatocytes of the testis and ovarian follicles. DGKη1 was
distributed in the oviductal epithelium of the ovary and the luminal epithelium of the uterus. Intriguingly, DGKη3 was
strongly expressed in the secondary spermatocytes and round spermatids of the testis. DGKκ was distributed in the
primary and secondary spermatocyte of the testis.
Conclusion: These results indicate that the expression patterns of the type II DGK isoforms δ2, η1, η3 and κ differ from
each other, suggesting that these DGK isoforms play specific roles in distinct compartments and developmental stages
of the reproductive organs, especially in the processes of spermatogenesis and oocyte maturation.
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Diacylglycerol kinase (DGK) phosphorylates diacylglycerol
(DG) to generate phosphatidic acid (PA) [1-4]. DG, which
is liberated from phosphatidylinositol 4,5-bisphosphste
and phosphatidylcholine upon cell stimulation, regulates
a wide range of cellular functions. For instance, DG is
an allosteric activator of conventional and novel protein
kinase Cs (PKCs), Unc-13 and Ras guanyl nucleotide-
releasing protein [5-7]. Therefore, DGK consumes DG
and is thus responsible for attenuating DG-mediated sig-
nals. PA, the reaction product of DGK, has also been re-
ported to regulate a number of signaling proteins such as
phosphatidylinositol-4-phosphate 5-kinase, Ras GTPase-
activating protein, C-Raf, mammalian target of rapamycin* Correspondence: sakane@faculty.chiba-u.jp
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unless otherwise stated.and atypical PKC [8-10]. Therefore, DGK is thought to
play roles not only in the downregulation of DG signaling
but also in the production of another lipid mediator, PA.
It is well known that DGK represents a large enzyme
family. Ten mammalian DGK isozymes, namely α, β, γ,
δ, ε, ζ, η, θ, ι, and κ, which contain two or three charac-
teristic cysteine-rich, zinc finger-like C1 domains and
the catalytic region in common, are subdivided into five
groups according to their structural features [1-4]. The
type II DGK [11] comprises the δ [12], η [13] and κ [14]
isozymes. The occurrence of alternative splicing was re-
ported for DGKδ (δ1 and δ2) [15] and DGKη (η1 and η2)
[16]. All of the type II DGK isoforms possess a pleck-
strin homology domain at their N termini and a sepa-
rated catalytic domain, and DGKs δ1, δ2 and η2 but
not DGKs η1 and κ contain a sterile α-motif domain at
their C termini. It has been reported that DGKs δ1, δ2
and η2 formed oligomers through interactions amongal. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Expression of type II DGK mRNAs (A) and proteins (B)
in the reproductive organs: testis, ovary and uterus. (A) RT-PCR
analysis of the mRNA from the reproductive organs was performed:
testes from 12-week-old male mice and ovaries and uteruses from 12-
week-old female mice. The panels show that 999-bp cDNA fragments
were amplified for DGKδ (35 cycles), 826-bp cDNA fragments were
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mation regulates the activities and subcellular localiza-
tions of these DGK isoforms [15-19]. DGKs δ2 and κ
contain the Pro-rich 52 residues [15] and the 33 tan-
dem repeats of Glu-Pro-Ala-Pro [14] extending from
the N terminus, respectively.
Based on the analysis of DGKδ-knockout mice, it was re-
cently reported that DGKδ regulates the epidermal growth
factor receptor pathway in epithelial cells of the lung and
skin [20] and insulin receptor signaling in skeletal muscle
[21,22] by modulating PKC activity. We recently reported
that DGKη is expressed in stomach cancer and HeLa cer-
vical cancer cells and that it is required for the Ras/B-Raf/
C-Raf/MEK/ERK signaling cascade, which is activated by
the epidermal growth factor [23]. Type II DGKs have been
implicated in several diseases [24]. For example, DGKδ is a
key enzyme that prevents insulin resistance and type 2 dia-
betes [21]. A female patient with a disrupted DGKδ gene
who exhibits seizures and a psychiatric disorder was found
[25]. DGKη was reported to be involved in lung cancer
[26]. A genome-wide association study implicated the
DGKη gene in the etiology of bipolar disorder [27,28]. A
genome-wide association study also indicated a potential
relationship between DGKκ and hypospadias [29].
Several reports have revealed that DGKδ, η and κ are
abundantly expressed in the reproductive organs, testis
and ovary [12-16]. However, the functions of DGKs δ, η
and κ in the reproductive organs remain unclear, and
not even their detailed distribution patterns in the or-
gans have been revealed. Therefore, in this study, we ex-
amined the expression and spatial distribution of the
DGKs δ2, η1 and κ proteins and mRNAs in the mouse
reproductive organs. The results indicate distinct expres-
sion patterns, which were obviously different from each
other. Moreover, we found a new splice variant of DGKη,
DGKη3, which was specifically expressed in the testis.amplified for DGKη (35 cycles), 842-bp cDNA fragments were amplified
for DGKκ (35 cycles) and 978-bp cDNA fragments were amplified for
mouse glyceraldehyde phosphate dehydrogenase (GAPDH, 35 cycles),
as determined through agarose gel electrophoresis. The asterisk
indicates a ~730-bp band that was amplified from the testis mRNA.
Representatives of five independent experiments with five male and
five female mice are shown. (B) The protein samples (30 μg) from
the indicated tissues of 10-week-old male and female mice were
detected by Western blotting using anti-DGKδ and DGKη anti-
bodies. Representatives of five independent experiments with five
male and five female mice are shown.Results
Expression of DGKδ, η and κ in the mouse
reproductive organs
We first confirmed the expression of DGKδ mRNA and
protein in the mouse reproductive organs: the testis,
ovary and uterus. The 999-bp cDNA fragment amplified
from DGKδ mRNA was strongly detected in the testis
and ovary and was clearly observed in the uterus by re-
verse transcription-polymerase chain reaction (RT-PCR)
(Figure 1A). The Western blot analysis showed that the
DGKδ2 protein (the splice variant 2, calculated molecu-
lar mass: 135 kDa [15]) was substantially expressed in
the testis and ovary and, to a lesser extent, in the uterus
(Figure 1B). The DGKδ1 protein (the splice variant 1,
calculated molecular mass: 130 kDa [12]) was not de-
tectable in the reproductive organs (Figure 1B).The RT-PCR results demonstrated that DGKη mRNA
was expressed strongly in the testis and ovary and moder-
ately expressed in the uterus (Figure 1A). The RT-PCR
product using DGKη mRNA from the testis (approxi-
mately 730 bp) was shorter than those obtained from the
ovary and uterus (the 826-bp cDNA fragment) (Figure 1A).
Therefore, the shorter product (~730 bp) is specifically
generated in the testis. The Western blot analysis showed
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molecular mass: 128 kDa [13]) was strongly detected in
the ovary and uterus (Figure 1B). The DGKη1 protein
was detected at a slightly higher position (132 kDa) in
the SDS-polyacrylamide gel electrophoresis results than
that corresponding to the calculated molecular mass
(Figure 1B). The DGKη2 protein (the splice variant 2,
calculated molecular mass: 135 kDa (139 kDa in SDS-
polyacrylamide gel electrophoresis) [16]) was not de-
tected in the reproductive organs.
The sequence analysis of the RT-PCR product amplified
from the testis mRNA revealed that the shorter mRNA
(precisely 733 bp) is an alternative splicing product of the
DGKη gene in which exon 26 is skipped (Figure 2). There-
fore, we designate this product DGKη3. Exon 26 of the
DGKη gene contains 93 bp and encodes 31 amino acid
residues. Therefore, no frame shift occurs due to alterna-
tive splicing. The exon/intron boundaries between exons
25 and 27 fulfill the GT/AG rule (Figure 2A). In addition
to the ovary and uterus, the 733-bp band failed to be de-
tected in the epididymis, sperm, vesicula seminalis, pros-
tate gland, brain and Neuro 2a neuroblastoma cells (data
not shown). These results further strongly suggest thatFigure 2 Alternative splicing products of DGKη. (A) The nucleotide seq
DGKη3 are shown. The nucleotide and amino acid numbers are indicated i
structure of the DGKη gene (exons 25–27) and the alternative splicing thatDGKη3 is specifically expressed in the testis. The alterna-
tive splicing product is anticipated to produce a shorter
DGKη protein with an expected molecular mass of
125 kDa (129 kDa as detected by SDS-polyacrylamide gel
electrophoresis). We detected a 129-kDa band that reacted
with anti-DGKη antibody in the testis (Figure 1B). How-
ever, we found that this band was also detected (data not
shown) in the extracts from the testis of a recently created
DGKη-knockout mouse (Isozaki, T. et al., unpublished
work). Therefore, although DGKη3 mRNA was strongly
expressed in the testis (Figure 1A), its protein band has
not yet been identified (Figure 1B). The DGKη3 protein
may be unstable and quickly degraded.
DGKκ mRNA was modestly expressed in the testis,
ovary and uterus (Figure 1A). DGKκ protein was not de-
tected in these mouse reproductive organs by Western
blotting using anti-human DGKκ antibody (data not
shown). Anti-DGKκ antibody against human DGKκ [14]
may not effectively recognize the murine DGKκ protein.
Distribution of DGKδ, η and κ mRNAs in the testis
We then performed in situ hybridization using the anti-
sense probe to examine the spatial distribution of DGKδ2uences and deduced amino acid sequences of DGKη1, DGKη2 and
n the left in italic and plain text, respectively. (B) The exon-intron
yields the two different forms (DGKη1/2 and DGKη3) are shown.
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sections were also hybridized with the sense probe as a
control, no distinct staining was detected (Figure 3). As
shown in Figure 3, DGKδ mRNA was mainly expressed in
primary spermatocytes. The mRNA was moderately de-
tected in the spermatogonia and, to a lesser extent, in the
secondary spermatocytes. However, no obvious staining of
DGKδ mRNA was detected in the round and elongated
spermatids and the Leydig cells. The expression intensities
of DGKδ in these testicular cells are summarized in
Table 1.
The RT-PCR results demonstrated that DGKη3 mRNA
but not DGKη1/2 mRNA was mainly detected in the
testis (Figure 1). Compared with DGKδ2 mRNA, DGKη3
mRNA was detected in the inner area of the testis.
DGKη3 mRNA was strongly expressed in the secondary
spermatocytes and the round spermatids and was weakly
detected in the primary spermatocytes (Figure 3 and
Table 1). In the spermatogonia, elongated spermatids
and the Leydig cells, DGKη3 mRNA was not detectable.
No distinct staining was detected with the sense probe
as a control (Figure 3).Figure 3 In situ hybridization of the type II DGK mRNAs in the testis o
hybridized and detected with the antisense probe of the type II DGK mRN
controls. (B) High-magnification image of the seminiferous tubules. Represe
shown. Sg, spermatogonium; Ps, primary spermatocyte; Ss, secondary sperm
The scale bars in (A) represent 200 μm, and the scale bars in b represent 4Compared with the DGKδ and DGKη mRNAs, DGKκ
mRNA was expressed in the intermediate region be-
tween these isozymes in the testis. DGKκ mRNA was
substantially detected in the primary and secondary
spermatocytes and weakly distributed in the spermato-
gonia and round spermatids (Figure 3 and Table 1).
However, no obvious hybridization with DGKκ mRNA
was detected in the round and elongated spermatids and
the Leydig cells. No detectable staining was observed
with the sense probe as a control (Figure 3).Distribution of DGKδ, η and κ mRNAs in the ovary
and oviduct
DGKδ mRNA was broadly and modestly expressed in
the primary, secondary and mature follicles and the
corpus lutea (Figure 4 and Table 2). In the medulla,
weak staining was observed. DGKδ mRNA was weakly
detected in the oviductal epithelium (Figure 5). Al-
though the ovary and oviduct sections were also hy-
bridized with the sense probe as a control, no distinct
staining was detected (Figures 4 and 5).f a 12-week-old male mouse. (A) The type II DGK mRNAs were
As. The testis sections were also hybridized with the sense probes as
ntatives of three independent experiments with three male mice are
atocyte; Rs, round spermatid; Es, elongated spermatid; Lc, Leydig cell.
0 μm.
Table 1 Expression of type II DGKs in the testis
Testis
Spermatogonium Primary spermatocyte Secondary spermatocyte Round spermatid Elongated spermatid Leydig cell
DGK δ ++ +++ + – – –
DGK η – + ++ +++ – –
DGK κ + ++ +++ + – –
– : not detected; + : weakly detected; ++: moderately detected; +++: strongly detected.
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granulosa cells (follicular epithelium) of the primary and
secondary follicles (Figure 4 and Table 2). Moreover, the
mature follicles and corpus lutea, which are matured
from secondary follicles, only modestly expressed DGKη
mRNA. In the medulla, only weak staining was ob-
served. DGKη mRNA was strongly expressed in the ovi-
ductal epithelium (Figure 5 and Table 2). With the sense
probe as a control, no distinct staining was detected
(Figures 4 and 5).
DGKκ mRNA was slightly expressed in the medulla of
the ovary (Figure 4 and Table 2). However, DGKκ mRNAFigure 4 In situ hybridization of the type II DGK mRNAs in the ovary
hybridized and detected with the antisense probes of the type II DGK mRN
controls. (B) High-magnification image of the ovarian follicles (secondary fo
mice in different estrous cycles, essentially the same results were obtained.
are shown. Pf, primary follicle; Sf, secondary follicle; Mf, mature follicle; Cl, corp
200 μm, and the scale bars in (B) represent 40 μm.failed to be detected in the ovarian follicles and corpus
lutea. This mRNA was not detectable in the oviductal
epitherium (Figure 5 and Table 2). No obvious staining
was detected with the sense probe as a control (Figures 4
and 5).
Distribution of DGKδ, η and κ mRNAs in the uterus
DGKη mRNA was strongly expressed in the luminal
epithelium but not in the endometrium (Figure 6 and
Table 3). DGKη mRNA was clearly detected in the uter-
ine glands. However, the mRNA was not detectable in
the endometrium or myometrium (data not shown). Noof a 12-week-old female mouse. (A) The type II DGK mRNAs were
As. The ovary sections were also hybridized with the sense probes as
llicles). Although we observed histological specimens from five female
Representatives of five independent experiments with five female mice
us luteum; Gc, granulosa cell; M, medulla. The scale bars in (A) represent
Table 2 Expression of type II DGKs in the ovary and oviduct
Ovary
Primary follicle Secondary follicle Mature follicle Corpus luteum Medulla Oviductal epithelium
DGKδ ++ ++ ++ ++ + +
DGKη ++++ ++++ ++ ++ + ++
DGKκ – – – – + –
– : not detected; +: weakly detected; ++: strongly detected; ++++: very strongly detected.
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control (Figure 6).
DGKδ and DGKκ were broadly distributed and only
weakly detected in the luminal epithelium of the uterus
(Figure 6 and Table 3).
Discussion
This study provides the first detailed demonstration of
the expression and distribution of the type II DGK iso-
zymes DGKδ, η and κ in the mouse reproductive organs.
DGKδ, η and κ were expressed in the mouse reproduct-
ive organs, namely the testis, ovary and uterus. However,
their expression patterns were obviously different from
each other.Figure 5 In situ hybridization of the type II DGK mRNAs in the oviduc
hybridized and detected with the antisense probes of the type II DGK mRN
as controls. (B) High-magnification image of the ovarian oviduct. Represen
shown. Oe, oviductal epitherium. The scale bars in (A) represent 100 μm, aExon 26, which encodes 31 amino acid residues, is
skipped in the new alternative splicing product of the
DGKη gene, which is denoted DGKη3 (Figures 1 and 2).
DGKη3 was strongly expressed in the secondary sper-
matocytes and the round spermatids and was not
detected in other tissues, such as the ovary, uterus, epi-
didymis, sperm, vesicula seminalis, prostate gland, brain
and Neuro 2a neuroblastoma cells (data not shown), im-
plying that DGKη3 is specifically expressed in the testis,
particularly in the secondary spermatocytes and the
round spermatids. Therefore, this isoform plays a spe-
cialized role in these testicular cells. It is interesting to
investigate the functional difference that is generated by
the absence of exon 26. Although a motif search wast of a 12-week-old female mouse. (A) The type II DGK mRNAs were
As. The oviduct sections were also hybridized with the sense probes
tatives of four independent experiments with four female mice are
nd the scale bars in (B) represent 40 μm.
Figure 6 In situ hybridization of the type II DGK mRNAs in the uterus of a 12-week-old female mouse. (A) The type II DGK mRNAs were
hybridized and detected with the antisense probes of the type II DGK mRNAs. The uterus sections were also hybridized with the sense probes as
controls. (B) High-magnification image of the endometrial epithelium. Representatives of four independent experiments with four female mice are
shown. L, luminal epithelium; E, endometrium; Ug, uterine gland. The scale bars in (A) represent 200 μm, and the scale bars in (B) represent 40 μm.
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in the 31-amino acid sequence encoded by exon 26. A
protein database search indicated that the 31-amino acid
sequence showed high similarity (34.5% identity (79.3%
similar) in 29-aa overlap) with the C-terminal region (aa
797–825) of promyelocytic leukemia protein isoform 1,
which is a tumor suppressor of acute promyelocytic
leukemia [30,31]. However, the function of the region of
promyelocytic leukemia protein isoform 1 has not been
revealed. Therefore, the function of the 31-amino acid
sequence lacking in DGKη3 remains unclear at present.
In the testis, different expression patterns of type II DGKs







DGKδ + – – –
DGKη +++ – + –
DGKκ + – – –
–: not detected; +: weakly detected; +++: strongly detected.primary spermatocytes are developed from the spermato-
gonia through mitosis [32,33]. The secondary spermato-
cytes are then derived from the primary spermatocytes via
the first meiotic division. Moreover, the round spermatids
are generated from the secondary spermatocytes through
the second meiotic division. DGKδ2 mRNA was mainly
expressed in the spermatogonia and primary spermato-
cytes (Figure 3 and Table 1). Strong staining of DGKκ
was detected in the primary and secondary spermatocytes
(Figure 3 and Table 1). DGKη3 mRNA was strongly
expressed in the secondary spermatocytes and the round
spermatids (Figure 3 and Table 1). These results imply that
DGKs δ2, η3 and κ are involved in mitosis and the first
and second meiotic divisions, respectively. The sperm
fertilization-related protein equatorin, which is involved in
fusion with the oolemma, was reported to be strongly
expressed in secondary spermatocytes and round sperma-
tids and was weakly detected in the primary spermatocytes
[34]. This expression pattern of equatorin is very similar
to that of DGKη3 (Figure 3). Therefore, equatorin and
DGKη3 may be functionally linked to each other.
A genome-wide association study indicated that DGKκ
is involved in hypospadias [29]. Hypospadias is thought
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produced in Leydig cells [35]. However, DGKκ was not de-
tected in Leydig cells. Moreover, the expression pattern of
DGKκ was not similar to that of androgen receptor, which
was mainly expressed in spermatogonia and primary sper-
matocytes [36]. Therefore, a relationship between the dis-
tribution pattern of DGKκ and hypospadias was not found
in this study.
In the ovary, DGKη1 mRNA was strongly expressed in
the granulosa cells (follicular epithelium) of the primary
and secondary follicles and modestly detected in the ma-
ture follicles and corpus luteum (Figure 4). Because
granulosa cells are vigorously proliferated in the primary
and secondary follicles during the maturation of ovarian
follicles [37], it is possible that DGKη1 is involved in the
proliferation of granulosa cells. We reported that DGKη1
enhances cell proliferation through the activation of C-Raf
[23]. McPhillips, F. et al. reported that C-Raf (Raf-1),
which is expressed in granulosa cells, mediates growth
factor-stimulated growth in ovarian cancer [38]. There-
fore, these results allow us to speculate that DGKη1 is in-
volved in ovarian carcinogenesis through the activation of
C-Raf (Raf-1). DGKδ2 mRNA was also expressed in the
granulosa cells (follicular epithelium) of the primary and
secondary follicles and modestly detected in the mature
follicles and corpus luteum (Figure 4). However, its ex-
pression levels were not changed during the follicle devel-
opment. Therefore, the function of DGKδ2 is likely
different from that of DGKη1.
DGKη1 mRNA was strongly expressed in the luminal
epithelium of the uterus (Figure 6), and DGKδ2 and κ
mRNAs were weakly detected in these cells. Similar to the
granulosa cells in the ovary, the luminal epithelium prolifer-
ates during the estrus cycle [37]. Epidermal growth factor
receptor is known to be highly expressed in the luminal
epithelium [39]. Among type II DGKs, DGKη1 enhances
cell proliferation downstream of epidermal growth factor
receptor [23], and DGKδ2 activates epidermal growth fac-
tor receptor through inactivation of protein kinase C [20].
Therefore, these DGK isoforms may positively regulate pro-
liferation through the receptor in the luminal epithelium.
Conclusions
Our data demonstrate that the spatial expression pat-
terns of DGKs δ2, η1, η3 and κ in the murine reproduct-
ive organs are different from each other. These results
support the hypothesis that DGKs δ2, η1, η3 and κ can
play specific roles in distinct compartments and develop-
mental stages of the reproductive organs, especially in
the processes of spermatogenesis and oocyte maturation.
In addition, we revealed the existence of a new alterna-
tive splicing product of DGKη, which we denoted
DGKη3. We recently established DGKη-knockout mice
(Isozaki, T. et al. unpublished work). To analyze thereproductive organ-related phenotypes of the knockout
mice, it is important to understand the expression pat-
terns of DGKη in the reproductive organs. Studies are
underway to examine the physiological functions of
DGKη1 and η3 in the reproductive organs using the
newly established DGKη-knockout mice.
Methods
Animals and tissue preparation
C57BL/6 N mice were obtained from SLC Japan Inc.
(Shizuoka, Japan). Mouse tissues were removed immedi-
ately after decapitation. All of the procedures using experi-
mental animals were approved by the Ethics Committee
of Chiba University (No. 26–96) and were performed ac-
cording to the guidelines for the Care and Use of Labora-
tory Animals of Chiba University.
RT-PCR
The testis, ovary and uterus from 10 to 12-week-old
male and female mice were homogenized in QIAzol lysis
reagent (Qiagen, Venlo, Netherlands), and the total RNA
was isolated with a Direct-zol RNA MiniPrep kit (Zymo
Research, Irvine, CA, USA). cDNA synthesis was per-
formed with the Transcriptor First-Strand cDNA Syn-
thesis Kit (Roche Diagnostics, Mannheim, Germany),
using 0.5 μg of total RNA and random hexamer primers.
PCR amplification was performed using rTaq polymerase
(Toyobo, Osaka, Japan) and the following mouse DGKδ,
η and κ-specific oligonucleotide primers. The DGKδ
primers were the following: forward primer (nucleotide
positions 4506–4527, 5’-CGGGATCCGGAAGTGACA-
TATGCCATGAGA-3’) and reverse primer (nucleotide
positions 5484–5505, 5’-GGGGTACCTCCTTCATTC-
TATCCCTCTCCA-3’). The PCR conditions were as fol-
lows: 94°C for 3 min, 35 cycles of 94°C for 30 sec, 56°C
for 30 sec, and 72°C for 1.5 min, and 72°C for 5 min.
The DGKη primers were the following: forward primer
(nucleotide positions 2417–2436, 5’-GGGAATTCCGG-
GAGCTACTACAGAGATC-3’) and reverse primer (nu-
cleotide positions 3224–3243, 5’-GGGGGTCGACCTC
CACAGAGTGTAAGGCAC-3’). The PCR conditions
were as follows: 94°C for 3 min, 35 cycles of 94°C for
30 sec, 58°C for 30 sec, and 72°C for 2 min, and 72°C for
5 min. The DGKκ primers were the following: forward
primer (nucleotide positions 3758–3778, 5’-GGGAATT-
CACCTTGGGCAACTACAGTGTT-3’) and reverse pri-
mer (nucleotide positions 4581–4600, 5’-GGGGGTCG
ACGGGTCACTTAGAGGTCGAGT-3’). The PCR con-
ditions were as follows: 94°C for 3 min, 35 cycles of 94°C
for 30 sec, 50°C for 30 sec, and 72°C for 2 min, and 72°C
for 5 min. For normalization, the mouse glyceraldehyde-
3-phosphate dehydrogenase (GAPDH) mRNA was si-
multaneously amplified (35 cycles) using the following
GAPDH-specific oligonucleotide primers: forward primer
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GATTTGGCCGTATT-3’) and reverse primer (nucleotide
positions 1056–1079, 5’-CATGTAGGCCATGAGGTC-
CACCAC-3’). The PCR conditions were as follows: 94°C
for 3 min, 35 cycles of 94°C for 30 sec, 45°C for 30 sec,
and 72°C for 1 min, and 72°C for 5 min. The amplified
PCR products were separated by agarose gel electrophor-
esis and stained with ethidium bromide (Wako Pure
Chemical, Osaka, Japan).
The RT-PCR product amplified from the DGKη
mRNA in the testis was purified and then sequenced
using the DGKη-specific forward and reverse primers
described above. The sequencing was carried out by
Eurofins Genomics (Tokyo, Japan).
Western blotting
The testis, ovary and uterus from 10- to 12-week-old male
and female mice were homogenized in lysis buffer
(50 mM HEPES, pH7.2, 150 mM NaCl, and 5 mM MgCl2)
containing complete EDTA-free protease inhibitor cocktail
(Roche Diagnostics) and centrifuged at 1,000 × g for
5 min. The protein concentration in the supernatants was
determined using a bicinchoninic acid protein assay kit
(Thermo Scientific, Hudson, NH, USA). The tissue lysates
(30 μg of protein) were separated on SDS-PAGE, and the
separated proteins were transferred to a polyvinylidene
difluoride membrane (Pall Life Sciences, Port Washington,
NY, USA). The membrane was blocked with 5% skim milk
and incubated with an anti-DGKδ polyclonal antibody [15]
and an anti-DGKη polyclonal antibody (ProteinTech Group,
Chicago, IL, USA) overnight at 4°C. The immunoreactive
bands were visualized using a peroxidase-conjugated anti-
rabbit IgG antibody (Jackson ImmunoResearch Laborator-
ies, West Grove, PA, USA) and the ECL Western Blotting
Detection System (GE Healthcare Bio-Sciences, Piscataway,
NJ, USA).
Preparation of plasmids and digoxigenin-labeled Riboprobes
for in situ hybridization
The PCR products of DGKs from the mouse brain were
subcloned into the BamHI/KpnI and EcoRI/SalI sites of
the pBluescript SK (+) vector (Stratagene-Agilent Tech-
nologies, Santa Clara, CA, USA). The plasmids were cut
with either KpnI (Roche Diagnostics) or BamHI for DGKδ
mRNA, and with either SalI or EcoRI for DGKη and κ
mRNA to produce the sense or anti-sense probes. The
digoxigenin (DIG)-labeled probes were synthesized by
transcribing 3 μg of template linear DNA with T3 and T7
RNA polymerase (Promega, Madison, WI, USA) according
to the DIG RNA labeling kit protocol (Roche Diagnostics).
In situ hybridization
The testis, ovary and uterus isolated from 10- to 12-
week-old male and female mice were rapidly frozen in100% OCT compound (Tissue-Tek, Sakura Finetek USA,
Inc., Torrance, CA, USA) in a dry ice-hexane bath. The
frozen tissues were sectioned at 25-μm thickness (Leica,
Solms, Germany) and mounted on APS-coated slides
(S8441, Matsunami, Tokyo, Japan). The sections were
fixed in 4% paraformaldehyde in phosphate buffered sa-
line (PBS) (137 mM NaCl, 2.67 mM KCl, 8.09 mM
Na2HPO4・12H2O, and 1.47 mM KH2PO4) (Wako Pure
Chemical) for 20 min. The sections were treated with
proteinase K (1 μg/μl, Qiagen) for 30 min at 37°C and
fixed with 4% paraformaldehyde in PBS for 5 min. The
basic proteins were acetylated with 0.25% acetic anhyd-
rite in 0.1 M triethylamine (pH 8.0), and both before
and after this process, the slides were rinsed with PBS.
Pre-hybridization was carried out with hybridization buf-
fer (40% deionized formamide, 10% dextran sulfate, 1×
Denhard’s solution, 4× SSC (1× SSC: 0.15 M NaCl, and
15 mM sodium citrate), 10 mM dithiothreitol, 1 mg/ml
tRNA from baker’s yeast, 1 mg/ml boiled deoxyribo-
nucleic acid from salmon sperm, and 0.25 mg/ml DIG-
labeled riboprobe denatured at 65°C for 30 min) without
riboprobes for 30 min at 60°C. The hybridization was
performed overnight with hybridization buffer at 60°C.
At the end of the incubation period, the sections were
rinsed stepwise at 60°C with 4× SSC, 2× SSC in 50% de-
ionized formamide, and 0.1× SSC and blocked through a
30 min incubation with blocking reagent solution (Roche
Diagnostic). The sections were incubated for 30 min at
room temperature in the presence of anti-DIG Fab
fragments conjugated with alkaline phosphatase (1/
5,000 dilution) in blocking reagent solution. The staining
was eventually developed using nitroblue tetrazolium/5-
bromo-4-chloro-3-indolyl-phosphate staining solution ac-
cording to the DIG Nucleic Acid Detection Kit protocol
(Roche Diagnostic). We then performed light microscopic
observation of serial sections of histologic specimens.
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